News Daily News Study Suggests VKA Monotherapy Sufficient in Patients With A-fib but No CAD Yael L. Maxwell June 20, 2017
News Daily News Aspirin Use by Elderly Patients After Vascular Events Linked to More Bleeding, Especially GI Bleeds Michael O'Riordan June 14, 2017
News Daily News Use of DAPT Score Following PCI Validated in PRODIGY Study Yael L. Maxwell June 12, 2017
News Conference News EuroPCR 2017 Best Antiplatelet Therapy in Real-World PCI? European Registries Fuel the Debate Caitlin E. Cox May 22, 2017
News Conference News EuroPCR 2017 TOPIC: Replacing P2Y12 Inhibitors With Clopidogrel 1 Month After PCI Saves Money, Prevents Bleeding in ACS Yael L. Maxwell May 16, 2017
News Conference News EuroPCR 2017 EuroPCR 2017: New Stents, New Questions for PCI Today and Tomorrow as Angioplasty Turns 40 Shelley Wood May 12, 2017
News Daily News More Excess Bleeding and No Benefit With Triple Therapy After PCI, Meta-analysis Finds Todd Neale May 05, 2017
News Daily News Extended DAPT May Benefit Patients With CAD and PAD, but With Caveats L.A. McKeown May 03, 2017
News Daily News ‘Forgotten’ Patients With Mechanical Heart Valves Undergoing PCI Pose Clinical Conundrum Todd Neale April 27, 2017
News Daily News Thirty-Day Readmission in Acute MI Not Linked With Hospital Care or Clinical Outcomes Michael O'Riordan April 27, 2017
News Daily News Do NOACs Carry a Higher Risk of Acute MI? New Study Reopens Old Questions Todd Neale March 28, 2017
Presentation ACC 2017 A Multicenter Randomized Trial Evaluating Clinically Significant Bleeding with Low-Dose Rivaroxaban vs Aspirin, in Addition to P2Y12 inhibition, in ACS Presenter: Magnus Ohman March 27, 2017
News Conference News ACC 2017 VISION: High-Sensitivity Troponin Strongly Linked to Increased Death From Myocardial Injury After Noncardiac Surgery L.A. McKeown March 19, 2017
News Conference News ACC 2017 Replacing Aspirin With Low-Dose Rivaroxaban for Post-ACS Therapy Appears Safe Todd Neale March 18, 2017
News Conference News ACC 2017 FOURIER: Evolocumab Reduces Risk of CVD Events by 15% Compared With Placebo Michael O'Riordan March 17, 2017
News Daily News ‘Hub and Spoke’ Model Promises to Improve Access to PCI for STEMI in Low- and Middle-Income Countries L.A. McKeown March 14, 2017
News Conference News ACC 2017 ACC 2017: CVD Outcomes for Evolocumab, Intermediate-Risk TAVR, Coronary Physiology Tests, and More Shelley Wood March 10, 2017
News Daily News The Long and Short of It: DAPT Duration Choice After Stenting Gets Help From New Score Todd Neale March 10, 2017
Presentation JIM 2017 The Future of Long Term Antiplatelet therapy: Is life Long Aspirin Still Necessary? Presenter: Roxana Mehran February 10, 2017
News Daily News Less Than Half of ACS Patients Are Prescribed High-Potency Statin Therapy Michael O'Riordan January 18, 2017